Provided by Tiger Fintech (Singapore) Pte. Ltd.

Henry Schein

69.39
-1.0600-1.50%
Post-market: 69.450.0623+0.09%18:13 EDT
Volume:1.48M
Turnover:102.52M
Market Cap:8.62B
PE:22.75
High:69.94
Open:69.88
Low:68.77
Close:70.45
Loading ...

Company Profile

Company Name:
Henry Schein
Exchange:
NASDAQ
Establishment Date:
1932
Employees:
25000
Office Location:
135 Duryea Road,Melville,New York,United States
Zip Code:
11747
Fax:
- -
Introduction:
Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Directors

Name
Position
Stanley M. Bergman
Chairman, Chief Executive Officer, Director
Mark E. Mlotek
Executive Vice President, Chief Strategic Officer, Director
Anne H. Margulies
Director
Bradley T. Sheares
Director
Carol Raphael
Director
Carole T. Faig
Director
Deborah Derby
Director
Joseph L. Herring
Director
Kurt P. Kuehn
Director
Mohamad Ali
Director
Philip A. Laskawy
Director
Reed V. Tuckson
Director
Robert J. Hombach
Director
Scott Serota
Director

Shareholders

Name
Position
Andrea Albertini
Chief Executive Officer, Global Distribution and Technology
Bianka Wilson
Co-Chief Executive Officer, Global Oral Reconstruction Group
Brad Connett
Chief Executive Officer, North America Distribution Group
R. Steven Boggan
Co-Chief Executive Officer, Global Oral Reconstruction Group
Stanley M. Bergman
Chairman, Chief Executive Officer, Director
Tom Popeck
Chief Executive Officer
Michael S. Ettinger
Executive Vice President and Chief Operating Officer
Christine Sheehy
Senior Vice President, Chief Human Resources
Christopher Pendergast
Senior Vice President and Chief Technology Officer
James Mullins
Senior Vice President, Global Supply Chain
Kelly Murphy
Senior Vice President and General Counsel
Ronald N. South
Senior Vice President, Chief Financial Officer
Trinh Clark
Senior Vice President and Chief Global Customer Experience Officer
Walter Siegel
Senior Vice President and Chief Legal Officer
Mark E. Mlotek
Executive Vice President, Chief Strategic Officer, Director